Stay updated on Ponatinib for Medullary Thyroid Cancer Clinical Trial
Sign up to get notified when there's something new on the Ponatinib for Medullary Thyroid Cancer Clinical Trial page.

Latest updates to the Ponatinib for Medullary Thyroid Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedAdded help/navigation items (How to Read a Study Record, Common Questions, How to Join a Study) and a Revision: v3.6.0 notice. The 'Intervention / Treatment' label was reformatted to 'Intervention/Treatment' and the older 'Revision: v3.5.5' note was removed.SummaryDifference0.5%

- Check19 days agoChange DetectedA new page revision tag v3.5.5 has been added, replacing the previous v3.5.4 to reflect an update to the page's documentation/UI.SummaryDifference0.1%

- Check41 days agoChange DetectedAdded a new revision label 'Revision: v3.5.4' and removed the previous 'Revision: v3.5.3'. This reflects a backend page revision update rather than any change to study data or content.SummaryDifference0.1%

- Check55 days agoChange DetectedNo textual changes were captured in the provided data. The page content remains as published, with no additions or deletions recorded.SummaryDifference0.1%

- Check62 days agoChange DetectedThe page footer’s revision/build version was updated from v3.5.2 to v3.5.3, reflecting a platform change rather than any change to the clinical trial’s content.SummaryDifference0.1%

- Check69 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

Stay in the know with updates to Ponatinib for Medullary Thyroid Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ponatinib for Medullary Thyroid Cancer Clinical Trial page.